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Cryptosporidiosis, a protozoal disease which causes significant morbidity in humans, is one of the chief causes of diarrhoea in neonatal 
ruminants. although the parasite poses a significant threat to public health and animal health in Ireland, its epidemiology on the 
island is only poorly understood. Environmental studies have shown the waterborne parasite to be widespread in some untreated 
waterbodies around Ireland. The island’s hydrogeological situation, combined with high stocking rates of livestock and the absence 
of filtration from regular water treatment, render it vulnerable to large-scale outbreaks. This review discusses the parasite in the Irish 
context and underlines the need for a reference facility to provide active surveillance on the island.
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Pathology	 and	 prevalence	 of	 cryptosporidiosis	 in	
domestic	animals
Cryptosporidiosis in ruminants is said to be on the increase (Castro-
Hermida et al., 2002) and it is now considered a major disease and 
one of the main causes of morbidity and mortality in newborn 
livestock (Casey, 1991; Munoz et al., 1996; de Graaf et al., 1999). C. 
parvum is the predominant parasite in cattle, sheep and goats, while 
C. andersoni and C. bovis also occur in cattle (one C. bovis infection 
has also been reported from a two-week-old lamb: Fayer et al., 
2005). The latter two are not infective to humans and, apparently, 
are less pathogenic to cattle than C. parvum (Santin et al., 2004; 
Xiao et al., 2004). Cryptosporidiosis in calves, lambs and goat kids 
is characterised by diarrhoea, anorexia, abdominal pain, apathy and 
depression. It has been suggested that destruction of the intestinal 
epithelia by the parasite may also increase susceptibility to other 
enteric pathogens (Casey, 1991; de Graaf et al., 1999; Lefay et al., 
2001) but, so far, synergistic effects have not been reported (Browning 
et al., 1991; Munoz et al., 1996; Netherwood et al., 1996). Severe 
cases are characterised by excessive loss of fluid and electrolytes 
with subsequent metabolic acidosis, which may prove fatal in some 
circumstances (de Graaf et al., 1999; Constable, 2002). Generally, 
the disease lasts between three and 12 days with protracted oocyst 
shedding well beyond recovery (Casemore et al., 1997). There are no 
reports of clinical cryptosporidiosis in adult cattle, sheep or goats, 
although they may shed oocysts asymptomatically (Lorenzo-Lorenzo 
et al., 1993; Casemore et al., 1997; de Graaf et al., 1999; Causapé et al., 
2002;  Sturdee et al., 2003). 
The parasite is common in ruminants throughout Europe but 
reported prevalence rates vary widely.  Among calves up to 100% of a 
herd may be affected, especially if the animals are housed communally 
(Casemore et al., 1997; de Graaf et al., 1999; Joachim et al., 2003; 
Sturdee et al., 2003). In Ireland, two studies have been carried out 
in commercial beef abattoirs: they reported prevalences between 
5.5% (adult cattle only: de Waele et al., in press) and 7.3% (including 
both adults and calves: Moriarty et al., 2005) with a marked spring 
peak. In both studies, most infections were due to the non-zoonotic 
species C. andersoni. Among lambs and goat kids, particularly high 
prevalences of 40% to 70% have been reported from Spain (Munoz et 
al., 1996; Casemore et al., 1997; Castro-Hermida et al., 2002; Causapé 
et al., 2002). In the UK, infection rates appear to be somewhat 
lower: Sturdee et al. (2003) reported an average incidence of 23%. 
Information is not available about the prevalence of cryptosporidiosis 
in sheep or goats in Northern Ireland or in the Republic of Ireland. 
A study of the prevalence of cryptosporidiosis in a commercial deer 
herd reported widespread asymptomatic infections in both calves and 
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adult deer hinds associated with low levels of oocyst shedding all year 
around (Skerrett and Holland, 2001). Among all ruminants, incidence 
rates usually peak during calving and lambing seasons. This is thought 
to be due to the presence of large groups of highly susceptible 
neonates in close proximity to each other and to dams, which may 
experience a periparturient rise in oocyst shedding (Casemore et al., 
1997; Skerrett and Holland, 2001; Moriarty et al., 2005). 
The  importance  of  cryptosporidiosis  in  horses  in  unclear. 
Until  recently,  clinical  disease  was  thought  to  be  restricted 
to  immunodeficient  foals,  in  which  the  infection  can  spread 
throughout the intestine and bile duct and become life-threatening 
(Bjorneby, 1991). Later studies demonstrated cryptosporidiosis in 
immunocompetent foals and adult horses. In foals, the disease may be 
asymptomatic (Browning et al., 1991) or it may cause mild to severe 
diarrhoea, in which case it may become fatal (Grinberg et al., 2003; 
Chalmers et al., 2005; Chalmers and Grinberg, 2005;). There is a single 
report in the literature of Cryptospordium-associated diarrhoea in a 
mature horse (McKenzie and Diffay, 2000). Generally, infected mature 
horses shed small numbers of oocysts without developing clinical signs 
(Majewska et al., 2004). With the exception of a novel horse genotype 
identified in a single Prezwalski’s wild horse (Ryan et al., 2003a), the 
only Cryptosporidium species identified in horses is C. parvum. In the 
UK, reported prevalence rates in foals and horses range between 
3% and 20% (Netherwood et al., 1996; Sturdee et al., 2003; Chalmers 
et al., 2005a).  A study of 21 normal and 285 diarrhoeic foals from 
British and Irish stud farms reported prevalences of 27% and 29%, 
respectively (Browning et al., 1991).
Three species infect pigs: C. suis (formerly pig genotype I), pig genotype 
II and, occasionally, C. parvum (Ryan et al., 2003b; Ryan et al., 2004). 
Experimental Cryptosporidium infections in piglets may cause moderate 
illness with anorexia, vomiting and diarrhoea (Tzipori et al., 1981; de 
Graaf et al., 1999). In contrast, though widespread, natural infections 
appear to be largely asymptomatic in both piglets and adult pigs 
(Tzipori et al., 1981; Casemore et al., 1997; de Graaf et al., 1999).  
Clinical cryptosporidiosis in dogs and cats (caused by Cryptosporidium 
canis and Cryptosporidium felis, respectively) has only been reported 
from  animals  that  are  immunosuppressed  by  concurrent  viral 
infections such as canine distemper, parvoviral gastroenteritis, feline 
leukaemia or feline immunodeficiency (Morgan et al., 1998; Denholm 
et al., 2001; Fayer et al., 2001). Furthermore, it has been reported that 
dogs and cats only rarely act as asymptomatic carriers (Casemore 
et al., 1997; Fayer et al., 2001; Cirak and Bauer, 2004), while PCR 
screening has shown that many are chronically infected at levels that 
are too low to be detected microscopically (Professor Una  M. Ryan, 
personal communication, March 2006).
In chickens and other domestic fowl, extra-intestinal infections are 
much more common than in mammals. The parasite infects the 
microvillous regions of the digestive tract, the respiratory tract, 
the bursa of Fabricius and the urinary tract. Mortality rates may be 
high (de Graaf et al., 1999). It has been suggested that respiratory 
cryptosporidiosis is due to inhalation of oocysts associated with 
aerosolised faecal dust. This may be followed by intestinal infections 
as oocysts are coughed up and swallowed (Trampel et al., 2000). 
Respiratory infections are characterised by coughing, sneezing, dyspnea 
and rales (Fayer et al., 1997). Chickens with intestinal infections 
suffer diarrhoea and severe enteritis. Renal cryptosporidiosis is 
associated with pale and enlarged kidneys, while the ureters may 
become partially obstructed, resulting in visceral gout (Trampel et 
al., 2000). Most infections occur in chickens under 11 weeks of age 
(Goodwin and Brown, 1990; Fayer et al., 1997). The chief avian species 
are Cryptosporidium baileyi, Cryptosporidium galli and Cryptosporidium 
meleagridis.
diagnosis	and	detection
Most microbiological departments of larger hospitals now test for 
Cryptosporidium if requested by the clinician or if cryptosporidiodis 
is indicated by the clinical presentation or the age of the patient. 
In Northern Ireland, faecal samples from suspected animal cases 
are tested on request at the laboratories of the Department of 
Agriculture and Rural Development (Veterinary Sciences Division). 
In the Republic of Ireland, that service is available at the Regional 
Veterinary Laboratories, at the Veterinary Hospital, University 
College Dublin and at the Central Veterinary Research Laboratory, 
Abbotstown, Dublin. The majority of these laboratories use either 
modified Ziehl-Neelsen stain or phenol-auramine stain (OIE, 2004; UK 
National Reference Method 002: www.defra.gov.uk/animalh/diseases/
vetsurveillance/pdf/nrm-002crypto.pdf), or a combination of both, to 
detect oocysts (safefood website: www.safefoodonline.com/safefood/
login_extranet.asp; Lowery et al., 2001).
In the UK, the legal limit for the presence of Cryptosporidium is one 
oocyst/10 litres drinking water (UK Drinking Water Regulations 1999, 
S.I. No 1527). However, numerous outbreaks have been reported 
at oocyst concentrations well below this threshold (Report of 
Waterborne Cryptosporidiosis Subcommittee of the Scientific 
Advisory Committee, 2004). Current EU legislation does not set 
limits for Cryptosporidium oocysts in drinking water. Similarly, there 
are no guidelines for the presence of oocysts in food, even though 
the number of reported foodborne outbreaks is on the increase. To 
our knowledge there are currently three laboratories on the island 
that test environmental samples for the presence of Cryptosporidium 
oocysts: in Northern Ireland, the Water Service Northern Ireland, 
Altnagelvin, Derry and, in the Republic of Ireland, the Central 
Laboratory,  Dublin  City  Council,  Dublin  8,  and  City Analysts 
Ltd., Ringsend, Dublin 4. Detection of oocysts in water samples 
and viability testing involves immunomagnetic separation (IMS), 
immunofluorescence (IFA) and vital dye staining as recommended by 
the Drinking Water Inspectorate (Regulations 1999, SI No.1524. June 
1999) and the EPA (USEPA Methods 1622 and 1623).
Genotyping to species level helped to identify the sources of 
contamination responsible for the three outbreaks in Northern 
Ireland during 2000 and 2001 (Glaberman et al., 2002) and the 2002 
outbreak in Westmeath (Jennings and Rhatigan, 2002). However, in 
the absence of a National Cryptosporidium Reference Laboratory, 
genotyping is not routinely carried out, although this information 
would be vital for a better understanding of the chief transmission 
routes of the parasite on this island. 
Treatment
In most immunocompetent patients and young animals, the disease 
is self-limiting and resolves without chemical intervention. For the 
treatment of more severe cases, over 100 agents have been tested 
with varying degrees of success (Hommer et al., 2003). Currently, 
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the only drug approved by the US Food and Drug Administration 
for treatment of cryptosporidiosis in children is the anti-protozoal 
agent nitrazoxanidine (Alinia) (Carey et al., 2004). Although some 
studies  reported  obvious  benefits  to  both  immunocompetent 
and immunocompromised people (Carey et al., 2004; Smith and 
Corcoran, 2004), other workers have questioned its usefulness to 
HIV-infected patients (Zardi et al., 2005). Another drug paromomycin, 
an aminocyclitol antibiotic isolated from Streptomyces, was previously 
reported to alleviate symptoms and reduce oocyst excretion in 
human infections. More recently, inconsistent results have raised 
questions concerning its efficacy against human cryptosporidiosis 
(Harp, 2003; Siripanth et al., 2004; Zardi et al., 2005). 
To date, no agent has been approved for the prevention or therapy 
of  cryptosporidiosis  in  calves  (Jarvie  et  al.,  2005). Though  of 
questionable efficacy in humans, paromomycin was successfully used 
as a prophylaxis in dairy calves, where it reduced the duration and 
severity of diarrhoea (Fayer and Ellis, 1993). Other studies have 
shown that the efficiency of paromomycin can be improved by 
combined use with protease inhibitors (Hommer et al., 2003) or 
recombinant IL-12 (Gamra and el-Hosseiny,  2003). The antiprotozoal 
drug halofuginone lactate (Halocur), a synthetic quinazolinone, can 
delay the establishment of infections in calves and reduce the severity 
of cryptosporidiosis. During treatment, oocyst excretion is reduced, 
contributing to decreased contamination of the environment (Jarvie et 
al., 2005). However, low levels of oocyst shedding may recur following 
withdrawal of the drug (Lefay et al., 2001; Joachim et al., 2003). 
Unfortunately, both drugs have disadvantages that preclude their 
widespread use in food animals: both are relatively toxic and require 
exact doses. Paramomycin is very expensive. Decoquinate, which 
is highly effective against some other apicomplexans, was found by 
some to be beneficial in both infected calves and goat kids (Redman 
and Fox, 1994; Mancassola et al., 1997).  Others reported little activity 
against Cryptosporidium in vitro, or in vivo in calves or suckling mice 
(Lindsay et al., 2000; Moore et al., 2003).  The starch-derived excipient 
beta-cyclodextrin was shown to be highly effective as a prophylactic 
and therapeutic agent in neonatal lambs (Castro-Hermida et al., 2002). 
Promising results have also been achieved with a number of other 
drugs, such as lasalocid, nigericin (two ionophorous antibiotics) and 
alpha-cyclodextrin in vitro and in the murine model (Castro-Hermida 
et al., 2000; Giacometti et al., 2000; Castro-Hermida and Ares-Mazos, 
2003), but so far they have not been tried in ruminants. 
Since there is no drug that achieves the complete removal of 
Cryptosporidium  from  an  infected  host,  and  no  compound  is 
clearly recognised, widely accepted and immediately available as a 
prophylactic or therapeutic agent, the preferred treatment in both 
humans and domestic animals is supportive treatment. Generally, 
this consists of replacement of fluid and electrolytes, nutritional 
support and anti-diarrhoeal drugs. Broad-spectrum antibiotics, gastric 
protectants and anti-ulcer medication may also be beneficial. In 
humans, the use of antiretroviral agents (HAART), which cause 
increased CD4+ T-lymphocyte counts in immunocompromised 
individuals, has dramatically improved recovery and survival rates 
(Hunter and Nichols, 2002; Carey et al., 2004). The introduction of 
protease inhibitors (PIs) in HAART has had additional benefits, as PIs 
appear to directly interfere with the parasite life cycle (Hommer et al., 
2003; Smith and Corcoran, 2004; Zardi et al., 2005). 
Immunity
There is abundant evidence in the literature that adult animals 
(such as cattle, sheep, poultry, mice) are not usually pathologically 
affected by cryptosporidiosis (Goodwin and Brown, 1990; Lorenzo-
Lorenzo et al., 1993; Casemore et al., 1997; Fayer et al., 1997; de 
Graaf et al., 1999; Causapé et al., 2002; Sturdee et al., 2003). Even 
though they may become infected and shed oocysts, they show no 
clinical signs. It has been suggested that this may be due to innate 
resistance mechanisms, such as maturation of the gut microflora 
or of the intestinal epithelium, or other age-related changes, which 
occur in adult animals even if they have not previously been exposed 
to the pathogen (Harp, 2003). On the other hand, since oocyst 
contamination is common in the environment of most calves, and 
calves are likely to be exposed repeatedly from birth, it is difficult to 
separate age-related innate resistance from immunity acquired during 
a previous infection. The only study that investigated innate immunity 
to cryptosporidiosis found that calves raised in isolation from C. 
parvum remained susceptible to challenge until at least three months 
of age (Harp et al., 1990). On the other hand, numerous studies 
confirm that animals (including primates) are fully protected against 
clinical signs following re-infection although they may shed oocysts 
asymptomatically (Current and Snyder, 1988; Harp et al., 1990; Miller 
et al., 1990; Fayer et al., 1997; Trampel et al., 2000; Harp, 2003).
In  humans,  separation  of  innate  and  acquired  immunity  to 
cryptosporidiosis is even more problematic and may depend on the 
species of Cryptosporidium or, indeed, the strain. Incidence data indicate 
that children are more severely affected, however, it has been argued 
that this bias may be due to a greater likelihood that parents seek 
medical attention for a child with diarrhoea and that stool samples 
are collected for laboratory analysis. Statistics from the largest 
cryptosporidiosis outbreak ever recorded (in 1993, in Milwaukee, 
Wisconsin, which affected approximately 403,000 people) showed that 
the group aged 30 to 39 years was most severely affected (MacKenzie 
et al., 1994). It was discovered later that this outbreak had been due 
to C. hominis (Sulaiman et al., 2001). Human infectivity studies carried 
out with seronegative volunteers found previous infections with C. 
parvum conferred only partial resistance to re-infection. Challenge 
with the same isolate one year after the first infection resulted in less 
severe symptomatic infections and lower levels of oocyst excretion 
(Okhuysen et al., 1998). Similarly, Xiao et al. (2001) detected repeat 
infections (with homologous and heterologous genotypes of C. 
parvum, C. hominis and C. meleagridis) in HIV-negative children in Peru 
and concluded that acquired immunity against Cryptosporidium was 
only partial or short-lived. Innate and acquired immunity are primarily 
dependent on gamma-interferon and CD4 T-lymphocytes (Hunter and 
Nichols, 2002). Serum antibodies, although commonly observed in 
recovering and immune animals (Lorenzo-Lorenzo et al., 1993), seem 
to be of minor importance (Riggs, 2002). 
conclusion
Cryptosporidium causes serious recurrent disease in humans and is 
one of the major enteropathogens affecting neonatal ruminants. 
The Waterborne Cryptosporidiosis Subcommittee, set up by the 
Department of Health and Children in 2000, found that the pathogen 
posed a significant threat to both public health and animal health.   
Recognising the potential for large-scale waterborne outbreaks in 
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Ireland, the body called for a National Cryptosporidium Reference 
Laboratory responsible for typing of isolates and provision of expert 
advice (Report of Waterborne Cryptosporidiosis Subcommittee of 
the Scientific Advisory Committee, 2004 ). In 2004, a cross-border 
Cryptosporidium Research Network was set up to promote and 
facilitate interdisciplinary research and the transfer of information 
about cryptosporidiosis on the island of Ireland. In addition, facilities 
for genotyping Cryptosporidium to species and strain level has been 
set up in the Central Veterinary Laboratory and at University College 
Dublin. More such measures and collaborations between medical, 
veterinary and environmental scientists and health care professionals 
will be necessary to enhance our knowledge of cryptosporidiosis on 
the island and to avert or minimise future outbreaks. 
Cryptosporidium	in	Ireland:	recent	initiatives
In 2004, Professor Grace Mulcahy, School of Agriculture, Food 
Science and Veterinary Medicine, University College Dublin 
(UCD) set up the cross-border Cryptosporidium Research 
Network. Funded by ‘safefood’, the Food Safety Promotion Board, 
the network sets out to promote and facilitate interdisciplinary 
research and the transfer of information about cryptosporidiosis 
on the island of Ireland. 
Genotyping of cattleisolates has been carried out under Dr 
Tom Murphy at the Central Veterinary Laboratory since 2002. 
Professors Grace Mulcahy and Seamus Fanning have set up a 
facility for genotyping Cryptosporidium to species and strain level 
at the UCD School of Agriculture, Food Science and Veterinary 
Medicine. Dr Nicholas Holden, School Of Agriculture, Food 
Science and Veterinary Medicine, UCD and Dr Tom Murphy, 
Central Veterinary  Laboratory,  are  currently  setting  up  a 
project which will use a microbial risk assessment model to 
identify catchments where potable water is at high risk of being 
contaminated.
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clarification
Part one of this scientific paper appeared in the previous edition of 
the Irish Veterinary Journal [59 (8)	pp 442-447]. It has been noted that, 
within that article, the content of Figure 4 was not made immediately 
clear. Thus, for purposes of clarification, Figure 4 is repeated here, with 
highlighting (smaller box) of the relevant area..
Figure	4:	Identification of C. hominis (lanes 2, 3 and 5, 6) and C. parvum (lanes 4 
and 7) by PCR-RFLP. Digestion with the endonuclease Sspl results in products 
of approx 500 and 250bp in both spp. Digestion with the endonuclease Vspl 
renders products of approx 590 (C. hominis) and 610 bp (C. parvum). Lanes 1 
and 8 are molecular weight markers.
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